Skip to main contentAI and Advanced
/
FERMENTA · NSEBSE SENSEX74,189.44-0.20%BSE |
NIFTY 5023,214.6-0.01%NSE |
NIFTY BANK56,120.8-0.30%NSE |
NIFTY IT28,991.15-0.33%NSE |
NIFTY AUTO26,911.6+0.07%NSE |
NIFTY FMCG45,605.25+0.10%NSE |
NIFTY PHARMA26,140.05-0.02%NSE |
NIFTY 50022,533.75+0.01%NSE |
FE
NSE · Equity shares · Biotechnology & Drugs-5.00 · -1.06%
Fermenta Biotech FERMENTA
NSE:INR 468
BSE:INR 436
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for FERMENTA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 473
Day rangeINR 450 — INR 477.9
52-week rangeINR 248.85 — INR 580.45
Volume1.11 L
Market cap1,283.19
P/E17.77
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)525.42
Net Income (INR Cr)71.77
Rev Growth (5 Year %)6.85
EPS Growth (5 Year %)9.33
P/E Ratio17.77
Book Value139.33
EPS22.79
Price/BV3.36Computed
Research path: Interpret Fermenta Biotech's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
FERMENTAFermenta Biotech1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 647.94 | 614.48 | 547.83 |
| Cash Equivalents | 41.34 | Not available | 0 |
| Other Liabilities Total | 27.54 | 24.59 | 41.33 |
| Long Term Debt | 7.9 | 13.62 | 39.76 |
| Common Stock Total | 14.34 | 14.58 | 14.44 |
| Other Current Assets Total | 23.58 | 9.94 | 1.02 |
| Total Assets | 647.94 | 614.48 | 547.83 |
| Current Portof LT Debt/Capital Leases | 102.25 | 15.58 | 21.52 |
| Total Equity | 406.21 | 362.67 | 288.86 |
| Long Term Investments | 8.85 | 3.89 | 6.39 |
| Retained Earnings(Accumulated Deficit) | 391.88 | 350 | 262.79 |
| Total Common Shares Outstanding | 2.87 | 2.92 | 2.89 |
| Tangible Book Valueper Share Common Eq | 139.33 | 121.9 | 96.14 |
| Goodwill Net | 4.12 | 4.12 | 4.12 |
| Total Liabilities | 241.73 | 251.8 | 258.97 |
| Total Debt | 113.33 | 114.94 | 138.77 |
| Short Term Investments | 53.25 | 43.27 | 37.84 |
| Cashand Short Term Investments | 94.59 | 71.51 | 59.66 |
| Total Receivables Net | 117.31 | 127.81 | 86.83 |
| Accounts Receivable-Trade Net | 117.24 | 104.45 | 73.42 |
| Property/Plant/Equipment Total-Net | 223.34 | 232.16 | 253.47 |
| Minority Interest | -5.67 | -4.16 | -3.7 |
| Total Current Liabilities | 208.77 | 211.88 | 173.26 |
| Total Inventory | 152.54 | 123.65 | 89.07 |
| Accounts Payable | 77.15 | 77.49 | 64.9 |
| Other Currentliabilities Total | 29.37 | 37.86 | 16.56 |
| Total Long Term Debt | 11.08 | 19.49 | 48.07 |
| Intangibles Net | 2.62 | 3 | 7.16 |
| Other Long Term Assets Total | 19.37 | 32.29 | 25.53 |
| Note Receivable-Long Term | 1.62 | 3.79 | 9.41 |
| Total Current Assets | 388.02 | 335.23 | 241.75 |
| Capital Lease Obligations | 3.18 | 5.87 | 8.32 |
| Accumulated Depreciation Total | Not available | -117.68 | -101.54 |
| Accrued Expenses | Not available | 1.09 | 1.1 |
| Other Equity Total | Not available | -2.21 | -1.1 |
| Prepaid Expenses | Not available | 2.33 | 5.17 |
| Additional Paid-In Capital | Not available | 0.3 | 12.73 |
| Cash | Not available | 28.24 | 21.83 |
| Property/Plant/Equipment Total-Gross | Not available | 333.93 | 353.39 |
| Notes Payable/Short Term Debt | Not available | 79.86 | 69.18 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.88
Price to Sale Ratio2.44
Growth
Debt 5Yr CAGR %-13.36
Margins
Operating Margin 12m16.18
Operating Margin 5y Avg8.13
Net Profit Margin 12m13.37
Net Profit Margin 5y4.05
Yield
Dividend Yield %0.86
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk47.71
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,936.5 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,379.2 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,982.45 | 1.69 L | 72.73 | — |
| Cipla | INR 1,405.8 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,117.85 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 64.09%
- FII
- 0.13%
- Other
- 35.78%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Fermenta Biotech declares ₹3.75 dividend, schedules AGM - scanx.tradeMarket news · 20 Jul 2026, 7:04 pm
Fermenta Biotech declares ₹3.75 dividend, schedules AGM scanx.trade
Fermenta Biotech files BRSR for FY 2025-26 - scanx.tradeMarket news · 20 Jul 2026, 7:01 pm
Fermenta Biotech files BRSR for FY 2025-26 scanx.trade
Fermenta Biotech revenue rises 14% to ₹548 crore in FY26 - scanx.tradeMarket news · 20 Jul 2026, 6:30 pm
Fermenta Biotech revenue rises 14% to ₹548 crore in FY26 scanx.trade
Fermenta Biotech subsidiary FESPL to issue shares to Aasava - scanx.tradeMarket news · 20 Jul 2026, 6:04 pm
Fermenta Biotech subsidiary FESPL to issue shares to Aasava scanx.trade
Fermenta Biotech Ltd is Rated Sell - MarketsMojoMarket news · 19 Jul 2026, 12:13 am
Fermenta Biotech Ltd is Rated Sell MarketsMojo
Fermenta Biotech to host investor meet on July 23, 2026 - scanx.tradeMarket news · 17 Jul 2026, 5:59 pm
Fermenta Biotech to host investor meet on July 23, 2026 scanx.trade
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.3.7500 per share(75%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsAudited Results, Final Dividend & ESOP
Rusaka Markets Community
Discussion and sentiment for Fermenta Biotech
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- FERMENTA
- BSE Code
- 506414
Questions
Stock FAQ
What is the symbol and ISIN of Fermenta Biotech?
Fermenta Biotech has the symbol FERMENTA and ISIN - INE225B01021.
What is the current price of Fermenta Biotech?
Fermenta Biotech is currently trading at INR 468.00.
What are the year high and year low of Fermenta Biotech?
Fermenta Biotech has a year high of INR 580.45 and a year low of INR 248.85.
What is the market capitalization of Fermenta Biotech?
Fermenta Biotech has a market capitalization of INR 1,283.19 crore.
What is the P/E ratio of Fermenta Biotech?
Fermenta Biotech has a P/E ratio of 17.77.
What is the dividend yield of Fermenta Biotech?
Fermenta Biotech has a dividend yield of 0.86%.
How is the financial performance of Fermenta Biotech based on revenue, net income, and EPS?
Fermenta Biotech has revenue of INR 525.42 crore, net income of INR 71.77 crore, and EPS of INR 23.15.
What is the book value of Fermenta Biotech?
Fermenta Biotech has a book value of INR 139.33.
What is the debt-to-equity ratio of Fermenta Biotech?
Fermenta Biotech has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Fermenta Biotech?
Fermenta Biotech has a price-to-book ratio of 3.36 and a price-to-sales ratio of 2.44.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.